| Ranbaxy set for $400mn FCCB |
| Our Corporate Bureau / New Delhi February 13, 2006 |
| Issue likely to be announced today, part of war chest for European buys. Ranbaxy Laboratories Ltd is set to announce a $400-million foreign currency convertible bonds (FCCBs) issue tomorrow as it braces up for a couple of acquisitions in Europe. Besides the much-touted Betapharm Arzeniemittel GmbH bid in Germany, the Indian pharmaceuticals major is close to acquiring Romanian firms, Terapia and Sindan. Ranbaxy executives declined to comment but a pharmaceuticals industry source close to the development said, |
